Clinical Trials Browser

Lymphoma, Extranodal NK-T-Cell × Decitabine × Clear all

NCT04279379 2020-05-07

Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell